Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NILOTINIB vs NIROGACESTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NILOTINIB vs NIROGACESTAT: Safety Overview

Metric NILOTINIB NIROGACESTAT
Total FAERS Reports 23,171 497
Deaths Reported 4,543 7
Death Rate 19.6% 1.4%
Hospitalizations 4,846 54
Average Patient Age 56.5 yrs 45.2 yrs
% Female Patients 47.7% 69.6%
FDA Approval Date Dec 15, 2025 N/A
Manufacturer Novadoz Pharmaceuticals LLC SpringWorks Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Prescription N/A